Auckland, New Zealand, May 31, 2019 –(PR.com)– The ground-breaking plant-based dietary supplement calocurb� is rapidly expanding internationally. Last week Iceland joined the list of countries that the supplement is now available in, which includes the United States, China and New Zealand. According to calocurbs maker LifeStream there are plans to launch in Vietnam, Mexico and Malaysia very soon. This news comes on the heels of calocurb receiving phenomenal reviews worldwide and positive study findings:
Positive Independent Reviews
Becca Ludlum from My Crazy Good Life covered calocurb in a piece called Reasons I Use This Natural Weight Management Supplement. She writes that, while she was sceptical at first, she decided to try calocurb after learning that it had only three plant-based natural ingredients.
After a week or so of using the product, Becca describes, I notice that I feel less hungry, that is all. Being less hungry definitely makes me think about food less, which allows me to feel more in control of what I eat.
Becca also happily adds that there were no side effects, especially considering a drop in her blood sugar levels generally triggers a migraine, and that calocurb helps her stay on track on her diet.
The lifestyle site, On Better Living also shared a similar set of results in their post called Say Goodbye to Cravings with This 100% Plant-Based Supplement.
After taking calocurb for three consecutive nights, they write, calocurb definitely seems to be curbing my hunger in the evening. I havent snacked at all and Ive increased the duration of my fast from 16 to 18 hours… I feel satiated throughout the night without nausea or the jitters.
Positive Study Findings
The supplement itself is being regarded as a breakthrough in the war against obesity in light of positive study findings.
The first clinical trial confirmed the bitter plant ingredient – Amarasate extract – effectively suppressed appetite in study participants and reduced the amount of food they ate.
Dr. John Ingram, who led the research team from the Crown Research Institute, said that when calocurb is taken an hour before meals, lab trials on human cells showed the hops extract activated the human body’s “stop eating signal.”
In the study, 20 male volunteers were given the extract or a placebo after eating a standardised 578 calorie energy breakfast. They were asked to eat until they felt comfortably full at lunch and afternoon tea, and their energy intake was recorded. Blood samples and subjective ratings of appetite were taken throughout the day. The researchers found that the Amarasate extract stimulated significant increases in hormones that regulate appetite and reduced food intake by up to 944 kJ (226 calories).
It has taken the team six years to identify the plant and develop the extract for clinical testing said study lead Ingram, who presented the findings of the study at a European Obesity Summit in Sweden last month.
The extract targeted bitter taste receptors that work to increase a feeling of fullness in the gut, Ingram said. “What we have done is to target specific bitter taste receptors that we know are expressed by these cells to enhance the satiety signalling.”
Calocurb
Calocurb launched New Zealand and the US last year and is a 100% plant-based dietary supplement that supports weight management and appetite control in an organic and natural manner.
Amarasate is the active ingredient in calocurb, and is a specific New Zealand grown hop flower extract and developed by Plant & Food Research, the largest Crown Research Institute in New Zealand.
Let’s block ads! (Why?)
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…